|
|
|
|
2. Etiologie
|
|
|
|
|
2.6 Etiologie - Environnement
|
|
|
Widely used herbicide linked to cancer [Nature News & Comment]
|
|
|
|
|
|
Guyton
strongly defends the IARC process and insists that there is a set of
clear rules that lays out which studies can be considered by the experts
convened by the IARC. These are broadly limited to peer-reviewed
publications and government reports, leading to the rejection of a
number of industry-submitted studies.
|
|
|
|
|
|
|
|
3.4.1 Chimioprévention - aspirine
|
|
|
|
5. Traitements
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
|
|
5.2 Traitements - Pharma
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
|
|
|
6.1 Lutte - Observation
|
|
|
|
6.3 Lutte - Associations
|
|
|
|
6.5 Lutte - Médecines alternatives
|
|
|
|
6.6 Lutte - Publications
|
|
|
|
6.7 Lutte - DMP, Big Data & applis
|
|
|
|
6.8 Lutte - Communication
|
|
|